荃银高科(300087) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 440,361,052.90, representing a 49.66% increase compared to CNY 294,245,563.46 in the same period last year[4] - Net profit attributable to shareholders was CNY 20,415,502.56, a significant turnaround from a loss of CNY 2,071,685.35, marking an increase of 1,085.45%[4] - The net profit after deducting non-recurring gains and losses was CNY 17,314,536.66, compared to a loss of CNY 3,847,301.38, reflecting a 550.04% increase[4] - Basic and diluted earnings per share were both CNY 0.0459, a substantial increase from a loss of CNY 0.0048 per share in the same quarter last year, representing a 1,056.25% increase[4] - Net profit reached 29.86 million RMB, reflecting a significant growth of 815.37% year-on-year[20] - The company reported a net profit of approximately 439.34 million CNY, up from 418.93 million CNY, indicating an increase of about 4.9%[33] Cash Flow - The company's cash flow from operating activities showed a slight improvement, with a net outflow of CNY 119,969,801.96, down 2.70% from CNY 123,298,090.48 in the previous year[4] - Cash inflow from operating activities totaled CNY 509,233,962.90, a 32.31% increase from CNY 384,881,642.60 in the same period last year[11] - The net cash flow from operating activities was -$119.97 million, slightly improved from -$123.30 million year-over-year[44] - Cash outflow from operating activities totaled $629.20 million, compared to $508.18 million in the previous year[44] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,312,081,322.34, down 6.40% from CNY 3,538,394,311.20 at the end of the previous year[4] - Total current assets amounted to approximately 2.50 billion CNY, down from 2.73 billion CNY in the previous period, reflecting a decrease of about 8.4%[24] - The company's cash and cash equivalents decreased from approximately 878.84 million CNY to about 587.78 million CNY, a decline of approximately 33%[24] - Total liabilities decreased from approximately 1.89 billion CNY to about 1.62 billion CNY, a reduction of about 14.3%[30] - The company's total assets decreased from approximately 3.54 billion CNY to about 3.31 billion CNY, reflecting a decline of about 6.5%[33] Shareholder Information - The total number of common stock shareholders at the end of the reporting period was 52,203[12] - The largest shareholder, China Seed Group Co., Ltd., holds 20.37% of shares, totaling 92,520,965 shares[12] - The second-largest shareholder, Jia Guilan, owns 6.87% of shares, amounting to 31,200,672 shares[12] Strategic Initiatives - The growth in performance is primarily driven by the continuous increase in seed business, particularly in hybrid rice and corn varieties[20] - The company has made progress in its strategic acquisition to enhance market share and competitiveness in the seed industry[23] - The company plans to acquire 60% of Xinjiang Jinfengyuan Seed Industry Co., Ltd. for a transaction price of 206.74 million CNY, reduced from the initial price of 213 million CNY[23] Board and Management - The company completed the election of the fifth board of directors and supervisory board on January 24, 2022[20] - The first meeting of the fifth board of directors was held on January 29, 2022, where key management positions were appointed[22] Investment and Research - The company reported a significant increase in investment income, amounting to CNY 2,688,492.20, up 848.70% from CNY 283,386.96 in the previous year[11] - Research and development expenses were ¥14,284,423.59, slightly up from ¥13,904,299.42, indicating continued investment in innovation[34]